FDA’s New Draft Hospital/Health-System Compounding Guidance: What Does It Mean for Practice?

This podcast episode provides members with an overview of FDA’s new draft hospital and health system compounding guidance. We cover what’s changed from the previous draft guidance, what it means for practice and compliance, and what comes next with FDA advocacy.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

There are no comments yet.

Please log in to write the first comment.